FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Clinical Investigation Protocol Deviations

[ Price : $8.95]

FDA publishes a draft guidance on defining, identifying, and reporting protocol deviations in clinical investigations.

Updated POLARx Instructions is Class 1 Recall: FDA

[ Price : $8.95]

FDA says a Boston Scientific recall updating instructions for two cryoablation balloon catheters is Class 1.

CGMP Violations in Akorn Formulations Review

[ Price : $8.95]

FDA warns Akorn Formulations in Hyderabad, Telangana, India, about CGMP violations in its production of over-the-counter drugs for...

NEWSROOM CLOSED FOR THE HOLIDAYS

[ Price : $8.95]

FDA Webview closes its newsroom for the end-of-year Holiday Season, reopening Thursday, Jan 2, 2025.

Zimmer Biomet Stemless Shoulder System

[ Price : $8.95]

FDA clears a Zimmer Biomet 510(k) for the OsseoFit Stemless Shoulder System for total shoulder replacement.

CDER Right-to-Try Summaries Can Go Thru Portal

[ Price : $8.95]

CDER updates its CDER NextGen Portal to allow Right to Try annual summary submissions for CDER-regulated products.

Guide on Tech Specs for NASH Drug Data Sets

[ Price : $8.95]

FDA posts a final guidance entitled Technical Specifications for Submitting Clinical Trial Data Sets for Treatment of Noncirrhotic...

FDA Promotes Centralized Statistical Trial Monitoring

[ Price : $8.95]

FDA encourages drug sponsors to use centralized statistical monitoring to help keep an eye on clinical trial integrity issues.

McKinsey & Co. Pays $650 Million in Opioid Case

[ Price : $8.95]

McKinsey & Co. agrees to pay $650 million to settle both criminal and civil investigations into its advisory work with Purdue Phar...

DTC Ad Enforcement to Increase Under Trump: Panel

[ Price : $8.95]

Lawyers on a Food & Drug Law Institute enforcement panel warn that the incoming Trump administration is likely to target and seek ...